Skip to content
PoliticalRepoPoliticalRepo

Germany · Question · Schriftliche Frage

21/9017

mRNA-basierte Impfstoffe im Impfschema der Bundeswehr und Nutzen-Risiko-Bewertung der COVID-19-Impfung bei Soldaten

openGermany· German Bundestag· DE

Introduced

6 November 2026

Last action

6 November 2026 · Schriftliche Frage/Schriftliche Antwort

Status

Beantwortet

Sponsors

—

Subjects

Defence

Source updated

17 November 2026

Defence

Records

Official question 21/9017 from Germany at German Bundestag. Dated 6 November 2026. Status: Beantwortet.

Timeline

  1. 6 November 2026

    Schriftliche Frage/Schriftliche Antwort

    mRNA-basierte Impfstoffe im Impfschema der Bundeswehr und Nutzen-Risiko-Bewertung der COVID-19-Impfung bei Soldaten

    Source: BT

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

This file cannot be previewed here. Use View or Download.

Reading translation

Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.